RPRX logo

Royalty Pharma (RPRX) EBITDA

Annual EBITDA

$1.56 B
-$330.95 M-17.54%

December 31, 2024


Summary


Performance

RPRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXprofitabilitymetrics:

Quarterly EBITDA

$400.11 M
-$472.75 M-54.16%

December 31, 2024


Summary


Performance

RPRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXprofitabilitymetrics:

TTM EBITDA

$1.56 B
-$364.73 M-18.99%

December 31, 2024


Summary


Performance

RPRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

RPRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.5%-47.7%-17.5%
3 y3 years+8.8%-47.7%-17.5%
5 y5 years-43.5%-47.7%-17.5%

RPRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.5%+267.3%-54.2%+171.1%-19.0%+267.3%
5 y5-year-43.5%+267.3%-73.6%+171.1%-47.9%+267.3%
alltimeall time-43.5%+267.3%-73.6%+171.1%-47.9%+267.3%

Royalty Pharma EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$1.56 B(-17.5%)
$400.11 M(-54.2%)
$1.56 B(-19.0%)
Sep 2024
-
$872.86 M(+258.6%)
$1.92 B(+57.9%)
Jun 2024
-
$243.39 M(+509.1%)
$1.22 B(-11.3%)
Mar 2024
-
$39.96 M(-94.8%)
$1.37 B(-27.3%)
Dec 2023
$1.89 B(+345.4%)
$764.84 M(+355.0%)
$1.89 B(+237.4%)
Sep 2023
-
$168.11 M(-57.8%)
$559.36 M(-15.1%)
Jun 2023
-
$398.29 M(-28.4%)
$658.64 M(-17.6%)
Mar 2023
-
$556.04 M(-198.8%)
$798.92 M(+88.6%)
Dec 2022
$423.69 M(-70.4%)
-$563.08 M(-310.6%)
$423.69 M(-61.2%)
Sep 2022
-
$267.39 M(-50.4%)
$1.09 B(-0.4%)
Jun 2022
-
$538.56 M(+197.9%)
$1.10 B(-22.1%)
Mar 2022
-
$180.82 M(+69.9%)
$1.41 B(-1.5%)
Dec 2021
$1.43 B
$106.44 M(-60.9%)
$1.43 B(-17.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
$271.92 M(-68.0%)
$1.73 B(-18.3%)
Jun 2021
-
$849.91 M(+320.6%)
$2.12 B(+10.9%)
Mar 2021
-
$202.06 M(-50.7%)
$1.92 B(+1.8%)
Dec 2020
$1.88 B(-31.7%)
$410.27 M(-38.0%)
$1.88 B(-37.0%)
Sep 2020
-
$661.49 M(+3.1%)
$2.99 B(+5.2%)
Jun 2020
-
$641.90 M(+281.1%)
$2.84 B(+15.8%)
Mar 2020
-
$168.41 M(-88.9%)
$2.45 B(-10.9%)
Dec 2019
$2.75 B(+50.4%)
$1.52 B(+194.5%)
$2.75 B(+122.4%)
Sep 2019
-
$514.62 M(+102.9%)
$1.24 B(+71.1%)
Jun 2019
-
$253.67 M(-46.0%)
$723.63 M(+54.0%)
Mar 2019
-
$469.96 M
$469.96 M
Dec 2018
$1.83 B(+12.8%)
-
-
Dec 2017
$1.62 B
-
-

FAQ

  • What is Royalty Pharma annual EBITDA?
  • What is the all time high annual EBITDA for Royalty Pharma?
  • What is Royalty Pharma annual EBITDA year-on-year change?
  • What is Royalty Pharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Royalty Pharma?
  • What is Royalty Pharma quarterly EBITDA year-on-year change?
  • What is Royalty Pharma TTM EBITDA?
  • What is the all time high TTM EBITDA for Royalty Pharma?
  • What is Royalty Pharma TTM EBITDA year-on-year change?

What is Royalty Pharma annual EBITDA?

The current annual EBITDA of RPRX is $1.56 B

What is the all time high annual EBITDA for Royalty Pharma?

Royalty Pharma all-time high annual EBITDA is $2.75 B

What is Royalty Pharma annual EBITDA year-on-year change?

Over the past year, RPRX annual EBITDA has changed by -$330.95 M (-17.54%)

What is Royalty Pharma quarterly EBITDA?

The current quarterly EBITDA of RPRX is $400.11 M

What is the all time high quarterly EBITDA for Royalty Pharma?

Royalty Pharma all-time high quarterly EBITDA is $1.52 B

What is Royalty Pharma quarterly EBITDA year-on-year change?

Over the past year, RPRX quarterly EBITDA has changed by -$364.73 M (-47.69%)

What is Royalty Pharma TTM EBITDA?

The current TTM EBITDA of RPRX is $1.56 B

What is the all time high TTM EBITDA for Royalty Pharma?

Royalty Pharma all-time high TTM EBITDA is $2.99 B

What is Royalty Pharma TTM EBITDA year-on-year change?

Over the past year, RPRX TTM EBITDA has changed by -$330.95 M (-17.54%)